These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20210745)

  • 1. A highly controllable reconstituted cell-free system--a breakthrough in protein synthesis research.
    Ohashi H; Kanamori T; Shimizu Y; Ueda T
    Curr Pharm Biotechnol; 2010 Apr; 11(3):267-71. PubMed ID: 20210745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an insect cell-free system.
    Ezure T; Suzuki T; Shikata M; Ito M; Ando E; Utsumi T; Nishimura O; Tsunasawa S
    Curr Pharm Biotechnol; 2010 Apr; 11(3):279-84. PubMed ID: 20210743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purified cell-free systems as standard parts for synthetic biology.
    Matsubayashi H; Ueda T
    Curr Opin Chem Biol; 2014 Oct; 22():158-62. PubMed ID: 25438802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and refolding technologies for production of recombinant proteins.
    Arakawa T
    Curr Pharm Biotechnol; 2010 Apr; 11(3):231-2. PubMed ID: 20406165
    [No Abstract]   [Full Text] [Related]  

  • 5. The wheat-germ cell-free expression system.
    Takai K; Sawasaki T; Endo Y
    Curr Pharm Biotechnol; 2010 Apr; 11(3):272-8. PubMed ID: 20210744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribosome display with the PURE technology.
    Ueda T; Kanamori T; Ohashi H
    Methods Mol Biol; 2010; 607():219-25. PubMed ID: 20204860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-free translation reconstituted with purified components.
    Shimizu Y; Inoue A; Tomari Y; Suzuki T; Yokogawa T; Nishikawa K; Ueda T
    Nat Biotechnol; 2001 Aug; 19(8):751-5. PubMed ID: 11479568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein synthesis using a reconstituted cell-free system.
    Tuckey C; Asahara H; Zhou Y; Chong S
    Curr Protoc Mol Biol; 2014 Oct; 108():16.31.1-16.31.22. PubMed ID: 25271715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PURE technology.
    Shimizu Y; Ueda T
    Methods Mol Biol; 2010; 607():11-21. PubMed ID: 20204844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PURE mRNA display for in vitro selection of single-chain antibodies.
    Nagumo Y; Fujiwara K; Horisawa K; Yanagawa H; Doi N
    J Biochem; 2016 May; 159(5):519-26. PubMed ID: 26711234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in development of cell-free protein synthesis systems for fast and efficient production of recombinant proteins.
    Lee KH; Kim DM
    FEMS Microbiol Lett; 2018 Sep; 365(17):. PubMed ID: 30084930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient protein selection based on ribosome display system with purified components.
    Ohashi H; Shimizu Y; Ying BW; Ueda T
    Biochem Biophys Res Commun; 2007 Jan; 352(1):270-6. PubMed ID: 17113037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limiting factors of the translation machinery.
    Freischmidt A; Meysing M; Liss M; Wagner R; Kalbitzer HR; Horn G
    J Biotechnol; 2010 Oct; 150(1):44-50. PubMed ID: 20638424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mimicking the Escherichia coli cytoplasmic environment activates long-lived and efficient cell-free protein synthesis.
    Jewett MC; Swartz JR
    Biotechnol Bioeng; 2004 Apr; 86(1):19-26. PubMed ID: 15007837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid production of milligram quantities of proteins in a batch cell-free protein synthesis system.
    Kim TW; Kim DM; Choi CY
    J Biotechnol; 2006 Jul; 124(2):373-80. PubMed ID: 16487613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial: biopharmaceutical technologies.
    Jungbauer A
    Biotechnol J; 2007 Jun; 2(6):647. PubMed ID: 17570696
    [No Abstract]   [Full Text] [Related]  

  • 17. Cell-free synthesis and maturation of [FeFe] hydrogenases.
    Boyer ME; Stapleton JA; Kuchenreuther JM; Wang CW; Swartz JR
    Biotechnol Bioeng; 2008 Jan; 99(1):59-67. PubMed ID: 17546685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creating a completely "cell-free" system for protein synthesis.
    Smith MT; Bennett AM; Hunt JM; Bundy BC
    Biotechnol Prog; 2015; 31(6):1716-9. PubMed ID: 26289032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging trends in plasma-free manufacturing of recombinant protein therapeutics expressed in mammalian cells.
    Grillberger L; Kreil TR; Nasr S; Reiter M
    Biotechnol J; 2009 Feb; 4(2):186-201. PubMed ID: 19226552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced Production of Soluble Recombinant Proteins With an In Situ-Removable Fusion Partner in a Cell-Free Synthesis System.
    Kasi D; Nah HJ; Catherine C; Kim ES; Han K; Ha JC; Kim DM
    Biotechnol J; 2017 Nov; 12(11):. PubMed ID: 28891200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.